The charcot effect: The invention of mental illnesses

Journal of Constructivist Psychology

Volumn 20, Issue 4, 2007, Pages 309-336

  Pérez Álvarez, Marino ^a   García Montes, JoséM ^b  

^a UNIVERSITY OF OVIEDO   (Spain)

^b UNIVERSITY OF ALMERÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34547781705     PISSN: 10720537     EISSN: 15210650     Source Type: Journal    
DOI: 10.1080/10720530701503843     Document Type: Article

References (95)

1. Alden, L. E., & Taylor, C. T. (2004). Interpersonal processes in social phobia. Clinical Psychology Review, 24, 857-882.
2. American Psychiatric Association. (1968). Diagnostic and statistical manual of mental disorders (2nd ed.). Washington, DC: Author.
3. American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders (3rd ed.). Washington, DC: Author.
4. American Psychiatric Association. (1987). Dia, gnostic and statistical manual of mental disorders (3rd ed., rev.). Washington, DC: Author.
5. American Psychiatric Association. (1994). Dia, gnostic and statistical manual of mental disorders (4th. ed.). Washington, DC: Author.
6. American Psychiatric Association. (2000). Dia, gnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
7. Anderson, I. M. (2000). Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability. Journal of Affective Disorders, 58, 19-36.
8. Aneshensel, C. S. (1999). Mental illness as a career. Sociological perspectives. In C. S. Aneshensel & J. C. Phelan (Eds.), Handbook of the sociology of mental health (pp. 585-603). New York: Kluwer Academic/Plenum.
9. Antonuccio, D. O., Burns, D. B., & Danton, W. G. (2002). Antidepressants: A triumph of marketing over science? Prevention & Treatment, 5: Article 25. Retrieved November 20, 2005, from http://journals.apa.org/prevention/volumen5/toc-jul15-02.html.
10. Ayd, F. (1961). Recognizing the depressed patient with essentials of management and treatment. New York: Grune & Stratton.
11. Barry, A. (2005). Pharmaceutical matters: The invention of informed materials. Theory, Culture, & Society, 22, 51-69.
12. Baskin, T. W., Tierney, S. C., Minami, T., & Wampold, B. E. (2003). Establishing specificity in psychotherapy: A meta-analysis of structural equivalence of placebo controls. Journal of Consulting and Clinical Psychology, 71, 973-979.
13. Berkenkotter, C., & Ravotas, D.J. (2002). Psychotherapists as authors: Microlevel analysis of therapists’ written reports. InJ. S. Sadler (Ed.), Descriptions and prescriptions: Values, mental disorders, and the DSMs (pp. 251-268). Baltimore: TheJohns Hopkins University.
14. Berrios, G. E. (1996). The history of mental symptoms: Descriptive psychopathology since the nineteenth century. Cambridge, UK: Cambridge University Press.
15. Borges, S., & Waitzkin, H. (1995). Women’s narratives in primary care medical encounters. Women & Health, 23, 29-56.
16. Bracken, P., & Thomas, P. (2005). Postpsychiatry: Mental health in a postmodern world. New York: Oxford University Press.
17. Breggin, P. R. (2003/2004). Suicidality, violence, and mania caused by selective serotonin reuptake inhibitors (SSRIs): A review and analysis. International Journal of Risk & Safety in Medicine, 16, 31-49.
18. Brown, P. (1995). Naming and framing: The social construction of diagnosis. Journal of Health and Social Behavior (extra issue), 34-52.
19. Bruner, J. (1990). Acts of meaning. Cambridge, MA: Harvard University Press.
20. Capp, L., & Ochs, E. (1995). Constructing panic: The discourse of agoraphobia. Cambridge, MA: Harvard University Press.
21. Cohn & Wolfe. (n.d.). Launching Paxil for the treatment of social anxiety disorder. Retrieved May, 5, 2006, from http://members.fortunecity.com/partnersinwellness/id23-m.ht.
22. Dimaggio, G. (2006). Disorganized narratives in clinical practices. Journal of Constructivist Psychology, 19, 103-108.
23. Dohrenwend, B. P. (1999). Epidemiology of schizophrenia. In W. F. Gattaz & H. Hafner (Eds.), Search for the causes of schizophrenia, Vol. IV: Balance of the century (pp. 81-88). Darmstadt, Germany: Springer-Verlag.
24. Dougher, M.J. (2000). Clinical behavior analysis. Reno, NV: Context Press.
25. Elliott, C. (2003). Better than well: American medicine meets the American dream. New York: Norton & Norton.
26. Elliott, C., & Chambers, T. (2004). Prozac as a way of life. Chapel Hill: University of North Carolina Press.
27. Estroff, S. E. (1989). Self, identity and subjective experiences of schizophrenia: In search of the subject. Schizophrenia Bulletin, 15, 189-196.
28. Fabrega, H. (1989). The self and schizophrenia: A cultural perspective. Schizophrenia Bulletin, 15, 277-290.
29. Freemantle, N., Anderson, I. M., & Young, P. (2000). Predictive value of pharmacological activity for relative efficacy of antidepressant drugs. Metaregression analysis. British Journal of Psychiatry, 177, 292-302.
30. Geertz, G. (1986). Making experiences, authoring selves. In V. W. Turner & E. M. Bruner (Eds.), The anthropology of experience (pp. 373-380). Urbana: University of Illinois Press.
31. Gergen, K J. (1994). Realities and relationships: Soundings in social construction. Cambridge, MA: Harvard University Press.
32. Gergen, K. J. (2004). Construire la realité [Constructing reality] Paris: Editions du Seuil.
33. Glenmullen, J. (2000). Prozac backlash: Overcoming the dangers of Prozac, Zoloft, Paxil, and others antidepressants with safe, effective alternatives. New York: Simon & Shuster.
34. Hacking, I. (1995). Rewriting the soul: Multiple personality and the sciences of memory. Princeton, NJ: Princeton University Press.
35. Hafner, H., Maurer, K., Loffler, W., der Heiden, W., Stein, A., Konnecke, R., etal. (1999). Onset and prodromal phase as determinants of the course. In W. F. Gattaz & H. Hafner (Eds.), Search for the causes of schizophrenia, Vol. IV: Balance of the century (pp. 35-58). Darmstadt, Germany: Springer-Verlag.
36. Healy, D. (1997). The antidepressant era. Cambridge, MA: Harvard University Press.
37. Healy, D. (2004a). Let them eat Prozac: The unhealthy relationship between the pharmaceutical industry and depression. New York: New York University Press.
38. Healy, D. (2004b). Shaping the intimate: Influences on the experience of everyday nerves. Social Studies of Science, 34, 219-245.
39. Healy, D. (2005). Psychiatric drugs explained (4th ed.). Edinburgh: Elsevier.
40. Harrop, C., & Trower, P. (2001). Why does schizophrenia develop at late adolescence? Clinical Psychological Review, 21, 241-266.
41. Hofmann, S. G., Heinrichs, N., & Moscovitch, D. A. (2004). The nature and expression of social phobia: Toward a new classification. Clinical Psychology Review, 24, 769-797.
42. Hopper, K., & Wanderling, J. (2000). Revisiting the developed versus developing country distinction in course and outcome in schizophrenia: Results from IsoS, the WHO Collaborative Follow up Project. Schizophrenia Bulletin, 26, 835-846.
43. Horwitz, A. V. (2002). Creating mental illness. Chicago: University Chicago Press.
44. Jacobson, N. S., Martell, C. R., & Dimidjian, S. (2001). Behavioral activation treatment for depression: Returning to contextual roots. Clinical Psychology: Science and Practice, 8, 255-270.
45. Jenkins, J. H., & Barrett, R. J. (2004). Schizophrenia, culture, and subjectivity: The edge of experience. Cambridge, UK: Cambridge University Press.
46. Karp, D. A. (1996). Speaking sadness: Depression, disconnection, and the meanings of illness. New York: Oxford University Press.
47. Kleinman, A. (1980). Patient and healer in the context of culture: An exploration of the borderland between anthropology, medicine, and psychiatry. Berkeley: University of California Press.
48. Kramer, P. (1993). Listening to Prozac. New York: Viking Press.
49. Lacasse, J. R., & Leo, J. (2005). Serotonin and depression: A disconnect between the advertisements and the scientific literature. Plos Medicine, 2, 12, e92. Retrieved December 15, 2005, from http://www.plosmedicine.org.
50. Lally, S. J. (1989). “Does being in here mean there is something wrong with me?” Schizophrenia Bulletin, 15, 253-265.
51. Luhrmann, T. M. (2000). Of two minds: An anthropologist looks at American psychiatry. New York: Vintage Books.
52. Lysaker, P., & Lysaker, J. (2004). Schizophrenia as dialogue at the ends of its tether: The relationship of disruptions in identity with positive and negative symptoms. Journal of Constructivist Psychology, 17, 105-119.
53. Lysaker, P., & Lysaker, J. (2006). Psychotherapy and schizophrenia: An analysis of requirements of an individual psychotherapy for persons with profoundly disorganized selves. Journal of Constructivist Psychology, 19, 171-189.
54. Mancuso, J. C. (1993). Personal construct systems in the context of action. In S. C. Hayes, L. J. Hayes, H. W. Reese, & T. R. Sarbin (Eds.), Varieties of scientific contextualism (pp. 111-133). Reno, NV: Context Press.
55. Maturana, H. R. (1988). Reality: The search, for objectivity or the quest for a compelling argument. Irish Journal of Psychology, 9, 25-82.
56. McDaniel, P. (2001). Shrinking violets and Caspar Milquetoasts: Shyness and heterosexuality from the roles of the fifties to the rules of the nineties. Journal of Social History, 34, 547-568.
57. McNamee, S. (2002). The social construction of disorders: From pathology to potential. In J. D. Raskin & S. K. Bridges (Eds.), Studies in meaning: Exploring constructivist psychology (pp. 143-168). New York: Pace University Press.
58. Moncrieff, J. (2003). Is psychiatry for sale? An examination of the influence of the pharmaceutical industry on academic and practical psychiatry. Retrieved November 20, 2005, from http://www.critpsynet.freeuk.com/pharmaceuticalindustry.htm.
59. Montagne, M. (2001). Mass media representations as drug information for patients: The Prozac phenomenon. Substance Use & Misuse, 36, 1261-1274.
60. Moynihan, R., & Cassels, A. (2005). Selling sickness: How the world’s biggest pharmaceutical companies are turning us all into patients. New York: Nation Books.
61. Moynihan, R., Heath, I., & Henry, D. (2002). Selling sickness: The pharmaceutical industry and disease mongering. British Medical Journal, 324, 886-891.
62. Orr, J. (2000). Performing methods: History, hysteria, and the new science of psychiatry. In D. Fee (Ed.), Pathology and the postmodern: Mental illness as discourse and experience (pp. 49-73). London: Sage.
63. Perez-Alvarez, M. (2005). Psicología del Quijote [Psychology of Quixote]. Psi-cothema, 17, 303-310.
64. Perez-Alvarez, M., & García-Montes, J. M. (2004). Personality as a work of art. New Ideas in Psychology, 22, 157-173.
65. Perez-Alvarez, M., & García-Montes, J. M. (2006). Person, behaviour, and contingencies (an aesthetic view of behaviourism). InternationalJournal of Psychology, 41, 449-461.
66. Pignarre, P. (2001). Comment la depresion est devenue une epidemie [How depression became an epidemia]. Paris: Hachette.
67. Popper, K. (1963). Conjectures and refutations. London: Routledge & Kegan Paul.
68. Raskin, J. D. (2002). Constructivism in psychology: Personal construct psychology, radical constructivism, and social constructivism. In J. D. Raskin & S. K. Bridges (Eds.), Studies in meaning: Exploring constructivist psychology (pp. 1-25). New York: Pace University Press.
69. Raskin, J. D., & Lewandowski, A. M. (2000). The construction of disorder as human enterprise. In R. A. Neimeyer &J. D. Raskin (Eds.), Constructions of disorder: Meaning-making frameworks for psychotherapy (pp. 15-40). Washington, DC: American Psychological Association.
70. Romme, M., & Escher, S. (2000). Making sense of voices: The mental health professional’s guide to working with voice-hearers. London: Mind.
71. Rose, N. (2003). Neurochemical selves. Society (Nov.-Dec.) (pp. 46-59).
72. Sarbin, T. R. (1997). The poetics of identity. Theory and Psychology, 7, 67-82.
73. Sarbin, T. R. (2005). If these walls could talk: Places as stages for human drama. Journal of Constructivist Psychology, 18, 203-214.
74. Scheff, T. J. (1999). Being mentally ill: A sociological theory (3rd ed.). New York: Aldane de Gruyter.
75. Seikkula, J., Alakare, B., & Aaltonen, J. (2001a). Open dialogue in psicosis I: An introduction and case illustration. Journal of Constructivist Psychology, 14, 247-265.
76. Seikkula, J., Alakare, B., & Aaltonen, J. (2001b). Open dialogue in psicosis II: A comparison of good and poor outcome cases. Journal of Constructivist Psychology, 14, 267-284.
77. Seikkula, J., & Olson, M. E. (2003). The Open Dialogue Approach to acute psychosis: Its poetics and micropolitics. Family Process, 42, 403-418.
78. Shorter, E. (1992). From paralysis to fatigue: A history of psychosomatic illness in the modern era. New York: Free Press.
79. Shorter, E. (1997). A history of psychiatry. New York: Wiley.
80. Shorter, E. (2001). Historical review of diagnosis and treatment of depression. In A. Dawson & A. Tylee (Eds.), Depression: Social, and economic timebomb (pp. 25-30). London: BMJ Books.
81. Spanos, N. (1996). Multiple identities and false memories. Washington, DC: American Psychological Association.
82. Spitzer, R. L., Kroenke, K., & Williams, J. B. (1999). Validation of a self-report version of PRIME-MD: The PHQprimary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. Journal of the American Medical Association, 282, 1737-1744.
83. Stanley, C. M., & Raskin, J. D. (2002). Abnormality: Does it define us, or do we define it? In J. D. Raskin & S. K. Bridges (Eds.), Studies in meaning: Exploring constructivist psychology (pp. 123-142). New York: Pace University Press.
84. Szasz, T. S. (1961). The myth of mental illness. New York: Hoeber-Harper.
85. Turner, V. (1982). From ritual to theater: The human seriousness of play. New York: PAJ Publications.
86. Valenstein, E. S. (1998). Blaming the brain: The truth about drugs and mental health. New York: Free Press.
87. von Glaserfeld, E. (1995). Radical constructivism: A way of knowing and learning. London: The Falmer Press.
88. Wakefield, J. C. (1992). Disorder as harmful dysfunction: A conceptual critique of DSM-III-R’s definition of mental disorder. Psychological Review, 99, 232-247.
89. Wakefield, J. C. (1999). Mental disorder as a black box essentialist concept. Journal of Abnormal Psychology, 108, 465-472.
90. Wampold, B. E. (2001). The great psychotherapy debate: Models, methods, and findings. Mahwah, NJ: Lawrence Erlbaum.
91. Wampold, B. E. (2005). Establishing specificity in psychotherapy scientifically: Design and evidence issues. Clinical Psychology: Science and Practice, 12, 194-197.
92. Warner, R. (2004). Recovery from schizophrenia: Psychiatry and political economy (3rd ed.). New York: Bruner-Reutledge.
93. Young, A. (1995). The harmony of illusions: Inventing post-traumatic stress disorder. Princeton, NJ: Princeton University Press.
94. Zachar, P. (2001). Psychiatric disorders are not natural kinds. Philosophy, Psychiatry, and Psychology, 7, 167-182.
95. Zachar, P. (2003). The practical kinds model as a pragmatist theory of classification. Philosophy, Psychiatry, and Psychology, 9, 219-227.